Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III

被引：0

作者：

Brunner, Hermine ^{[1
]}

Ruperto, Nicolino ^{[2
]}

Quartier, Pierre ^{[3
]}

Constantin, Tamas ^{[2
]}

Alexeeva, Ekaterina ^{[2
]}

Kone-Paut, Isabelle ^{[4
]}

Marzan, Katherine ^{[5
]}

Wulffraat, Nico ^{[2
]}

Schneider, Rayfel ^{[5
]}

Padeh, Shai ^{[6
]}

Chasnyk, Vyacheslav ^{[6
]}

Wouters, Carine ^{[6
]}

Kuemmerle-Deschner, Jasmin B. ^{[6
]}

Kallinich, Tilmann ^{[6
]}

Lauwerys, Bernard ^{[7
,8
]}

Haddad, Elie

Nasonov, Evgeny L. ^{[6
]}

Trachana, Maria ^{[6
]}

Vougiouka, Olga ^{[6
]}

Leon, Karolynn ^{[9
]}

Vritzali, Eleni ^{[10
]}

Lheritier, Karine ^{[11
]}

Martini, Alberto ^{[6
]}

Lovell, Daniel ^{[5
]}

机构：

[1] PRCSG, Rheumatol, Cincinnati, OH USA

[2] PRINTO Ist Gaslini, Genoa, Italy

[3] Necker Enfants Malad Hosp, Paris, France

[4] Univ Paris Sud, Hop Kremlin Bicetre, Paris, France

[5] PRCSG, Cincinnati, OH USA

[6] PRINTO Ist Gaslini, Genoa, Italy

[7] Clin Univ St Luc, Brussels, Belgium

[8] Catholic Univ Louvain, Brussels, Belgium

[9] Novartis Pharmaceut, E Hanover, NJ USA

[10] Novartis Pharma AG, Immunol & Dermatol Franchise, Basel, Switzerland

[11] Novartis Pharma AG, Basel, Switzerland

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 66

页数：3

共 50 条

[31] Efficacy of Canakinumab in Systemic Juvenile Idiopathic Arthritis Patients Previously Exposed to Biologics
Brunner, Hermine I.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Berkun, Yackov
Calvo-Penedes, Inmaculada
Erguven, Mueferet
Goffin, Laurence
Hofer, Michael
Kallinich, Tilmann
Oliveira, Sheila
Uziel, Yosef
Viola, Stefania
Nistala, Kiran
Wouters, Carine
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Junge, Guido
Lovell, Daniel
Martini, Alberto
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[32] Efficacy of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) using JADAS Criteria - an Analysis of 12-Week Pooled Data
Ravelli, A.
Brunner, H. I.
Ruperto, N.
Quartier, P.
Consolaro, A.
Wulffraat, N. M.
Lheritier, K.
Gaillez, C.
Martini, A.
Lovell, D. J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1002 - S1003
[33] EVALUATION OF EFFICACY AND SAFETY OF CANAKINUMAB IN JAPANESE PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN PHASE III CLINICAL TRIAL, COMPOSED PREDOMINANTLY OF PATIENTS WITH PRIOR USE OF TOCILIZUMAB
Takei, S.
Hara, R.
Umebayashi, H.
Iwata, N.
Imagawa, T.
Shimizu, M.
Tomiita, M.
Seko, N.
Kitawaki, T.
Wang, G.
Yokota, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 499 - 500
[34] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
Brunner, Hermine, I
Quartier, Pierre
Alexeeva, Ekaterina
Constantin, Tamas
Kone-Paut, Isabelle
Marzan, Katherine
Schneider, Rayfel
Wulffraat, Nico M.
Chasnyk, Vyacheslav
Tirosh, Irit
Kallinich, Tilmann
Kuemmerle-Deschner, Jasmin
Wouters, Carine
Lauwerys, Bernard
Nikishina, Irina
Trachana, Maria
Vougiouka, Olga
Martini, Alberto
Lovell, Daniel J.
Levy, Jeremy
Vritzali, Eleni
Ruperto, Nicolino
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
[35] Marked Improvement In Patient Reported Outcomes Of Children With Active Systemic Juvenile Idiopathic Arthritis With Canakinumab Treatment - Results Of The Phase III Program
Schneider, Rayfel
Brunner, Hermine I.
Ruperto, Nicolino
Wulffraat, Nico
Quartier, Pierre
Brik, Riva
McCann, Liza
Foster, Helen E.
Frosch, Michael
Gerloni, Valeria
Harel, Liora
Len, Claudio
Houghton, Kristin
Joos, Rik
Abrams, Ken
Lheritier, Karine
Kessabi, Sophia
Martini, Alberto
Lovell, Daniel J.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S111 - S112
[36] Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis
Brunner, Hermine, I
Ruperto, Nicolino
Ramanan, Athimalaipet, V
Horneff, Gerd
Minden, Kirsten
Penades, Inmaculada Calvo
Alexeeva, Ekaterina
Cleary, Gavin
Stern, Sara M.
Kone-Paut, Isabelle
Velazquez, Maria del Rocio Maldonado
Rabinovich, C. Egla
Remesal, Agustin
Silva, Clovis Artur
Nikishina, Irina
Zucchetto, Mauro
Brockwell, Laura
Gordon, Oliver
Nagel, Sandra
De Benedetti, Fabrizio
[J]. RHEUMATOLOGY, 2024,
[37] Long Term Safety of Drugs in Systemic Juvenile Idiopathic Arthritis
Gimenez, Ana Isabel Rebollo
Carlini, Luca
Miettunen, Paivi
Alexeeva, Ekaterina
Myrup, Charlotte
Nicolai, Rebecca
Trachana, Maria
Stenevicha, Valda
Ailioaie, Constantin
Tsitsami, Elena
Cochino, Alexis-Virgil
Pallotti, Chiara
Scala, Silvia
Pistorio, Angela
Vastert, Sebastiaan
Swart, Joost
Ruperto, Nicolino
[J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 697 - 698
[38] Long-Term Efficacy and Safety of Adalimumab for up to 6 Years in Patients with Juvenile Idiopathic Arthritis
Lovell, Daniel J.
Ruperto, Nicolino
Reiff, Andreas
Jung, Lawrence K.
Higgins, Gloria
Kone-Paut, Isabelle
Jones, Olcay Y.
McIlraith, Melissa J.
Andhivarothai, Nupun
Kupper, Hartmut
Giannini, Edward H.
Peterson, Theresa
Martini, Alberto
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S99 - S99
[39] Safety and Effect of Canakinumab in Patients with systemic juvenile Arthritis
Burgess, Stephanie
[J]. AKTUELLE RHEUMATOLOGIE, 2019, 44 (02) : 93 - 93
[40] EFFICACY AND SAFETY OF CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS - EXPERIENCE USING DATA OF THE BIKER REGISTRY
Horneff, Gerd
Lilienthal, Eggert
Trauzeddel, Ralf
Hospach, Toni
Kallinich, Tilmann
Dressler, Frank
Sailer-Hoeck, Michaela
Ganser, Gerd
Weller-Heinemann, Frank
Heubner, Georg
Urban, Andreas
Ruehlmann, Michael
Rietschel, Christoph
Hufnagel, Markus
Emminger, Wolfgang
Klein, Ariane
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 966 - 966

← 1 2 3 4 5 →